Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss

Por Stubelius, Alexandra, Andersson, Annica, Holmdahl, Rikard, Ohlsson, Claes, Islander, Ulrika, Carlsten, Hans
Publicado no BMC Musculoskelet Disord (2016)

Periarticular Bone Loss in Antigen-Induced Arthritis

Por Engdahl, Cecilia, Lindholm, Catharina, Stubelius, Alexandra, Ohlsson, Claes, Carlsten, Hans, Lagerquist, Marie K
Publicado em 2013

Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis

Por Islander, Ulrika, Jochems, Caroline, Stubelius, Alexandra, Andersson, Annica, Lagerquist, Marie K, Ohlsson, Claes, Carlsten, Hans
Publicado em 2011

Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis

Por Andersson, Annica, Bernardi, Angelina I., Stubelius, Alexandra, Nurkkala-Karlsson, Merja, Ohlsson, Claes, Carlsten, Hans, Islander, Ulrika
Publicado no Rheumatology (Oxford) (2016)

Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis

Por Andersson, Annica, Stubelius, Alexandra, Karlsson, Merja Nurkkala, Engdahl, Cecilia, Erlandsson, Malin, Grahnemo, Louise, Lagerquist, Marie K, Islander, Ulrika
Publicado no Arthritis Res Ther (2015)

Trabecular bone loss in collagen antibody-induced arthritis

Por Grahnemo, Louise, Andersson, Annica, Nurkkala-Karlsson, Merja, Stubelius, Alexandra, Lagerquist, Marie K., Svensson, Mattias N. D., Ohlsson, Claes, Carlsten, Hans, Islander, Ulrika
Publicado no Arthritis Res Ther (2015)

The role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis

Por Engdahl, Cecilia, Börjesson, Anna E, Forsman, Huamei F, Andersson, Annica, Stubelius, Alexandra, Krust, Andree, Chambon, Pierre, Islander, Ulrika, Ohlsson, Claes, Carlsten, Hans, Lagerquist, Marie K
Publicado no Arthritis Res Ther (2014)

The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified

Por Movérare-Skrtic, Sofia, Börjesson, Anna E., Farman, Helen H., Sjögren, Klara, Windahl, Sara H., Lagerquist, Marie K., Andersson, Annica, Stubelius, Alexandra, Carlsten, Hans, Gustafsson, Jan-Åke, Ohlsson, Claes
Publicado em 2014